Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F20%3A10414089" target="_blank" >RIV/00216208:11140/20:10414089 - isvavai.cz</a>
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=yu1FcfHyeG" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=yu1FcfHyeG</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1001/jamaoncol.2020.0286" target="_blank" >10.1001/jamaoncol.2020.0286</a>

Result language
angličtina
Original language name
Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer
Original language description
In a recent JAMA Oncology article, Mukama et al1 reported results of a nationwide cohort study to identify the risk-adapted starting age for breast cancer screening in patients with a family history. The authors proposed an earlier screening start for women with a family history compared with women without a family history. This particular method of assessing the risk-adapted starting age for breast cancer screening was introduced by Brandt et al2 in 2010 by a team that included the 2 senior authors of the article by Mukama et al.1 Curiously, this article was not cited by Mukama et al.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology

Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)